Skip to main content

Published locations for FDA updates hydrochlorothiazide label to include nonmelanoma skin cancer risk

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA updates hydrochlorothiazide label to include nonmelanoma skin cancer risk

User login

  • Reset your password
  • /content/fda-updates-hydrochlorothiazide-label-include-nonmelanoma-skin-cancer-risk
  • /edermatologynews/article/227351/hypertension/fda-updates-hydrochlorothiazide-label-include
  • /familypracticenews/article/227351/hypertension/fda-updates-hydrochlorothiazide-label-include
  • /internalmedicinenews/article/227351/hypertension/fda-updates-hydrochlorothiazide-label-include
  • /oncologypractice/article/227351/hypertension/fda-updates-hydrochlorothiazide-label-include
  • /jcomjournal/article/227351/hypertension/fda-updates-hydrochlorothiazide-label-include-nonmelanoma
  • /hematology-oncology/article/227351/hypertension/fda-updates-hydrochlorothiazide-label-include
  • /ecardiologynews/article/227351/hypertension/fda-updates-hydrochlorothiazide-label-include
  • /cardiology/article/227351/hypertension/fda-updates-hydrochlorothiazide-label-include-nonmelanoma
  • /internalmedicine/article/227351/hypertension/fda-updates-hydrochlorothiazide-label-include
  • /dermatology/article/227351/hypertension/fda-updates-hydrochlorothiazide-label-include-nonmelanoma
  • /familymedicine/article/227351/hypertension/fda-updates-hydrochlorothiazide-label-include-nonmelanoma
  • /chestphysician/article/227351/hypertension/fda-updates-hydrochlorothiazide-label-include-nonmelanoma